Reliability of efficacy in men with erectile dysfunction treated with tadalafil once daily after initial success

International Journal of Impotence Research

Volumn 22, Issue 1, 2010, Pages 1-8

  Shabsigh, R ^a   Donatucci, C ^b   Costabile, R ^c   Perelman, M A ^d   Burns, P ^e   Zeigler, H ^e   Wong, D G ^e  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e Lilly USA   (United States)

Author keywords

Erectile dysfunction; Response to treatment; Tadalafil

Indexed keywords

PLACEBO; TADALAFIL;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ERECTILE DYSFUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELIABILITY; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; TREATMENT RESPONSE;

AGED; CARBOLINES; COITUS; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 5; DOUBLE-BLIND METHOD; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; PHOSPHODIESTERASE INHIBITORS; REPRODUCIBILITY OF RESULTS; SEXUALITY; TREATMENT OUTCOME;

EID: 75149153686     PISSN: 09559930     EISSN: 14765489     Source Type: Journal    
DOI: 10.1038/ijir.2009.29     Document Type: Article

References (14)

1. NIH Consensus Conference. Impotence. NIH Consensus Development Panel on Impotence. JAMA 1993; 270: 83-90.
2. Ayta IA, McKinlay JB, Krane RJ. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences. BJU Int 1999; 84: 50-56.
3. McKinlay JB. The worldwide prevalence and epidemiology of erectile dysfunction. Int J Impot Res 2000; 12(Suppl 4): S6-S11.
4. Lue TF, Giuliano F, Montorsi F, Rosen RC, Andersson KE, Althof S et al. Summary of the recommendations on sexual dysfunctions in men. J Sex Med 2004; 1: 6-23. (Pubitemid 40424662)
5. Schulman CC, Shen W, Stothard DR, Schmitt H. Integrated analysis examining first-dose success, success by dose, and maintenance of success among men taking tadalafil for erectile dysfunction. Urology 2004; 64: 783-788.
6. Montorsi F, Hellstrom WJ, Valiquette L, Bastuba M, Collins O, Taylor T et al. Vardenafil provides reliable efficacy over time in men with erectile dysfunction. Urology 2004; 64: 1187-1195.
7. Fugl-Meyer AR, Lodnert G, Bränholm IB, Fugl-Meyer KS. On life satisfaction in male erectile dysfunction. Int J Impot Res 1997; 9: 141-148.
8. Althof SE. Quality of life and erectile dysfunction. Urology 2002; 59: 803-810.
9. Porst H, Giuliano F, Glina S, Ralph D, Casabé AR, Elion-Mboussa A. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5mg and 10mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol 2006; 50: 351-359.
10. Rajfer J, Aliotta PJ, Steidle CP, Fitch III WP, Zhao Y, Yu A. Tadalafil dosed once a day in men with erectile dysfunction: a randomized, double-blind, placebo-controlled study in the US. Int J Impot Res 2007; 19: 95-103.
11. Hatzichristou D, Gambla M, Rubio-Aurioles E, Buvat J, Brock GB, Spera G et al. Efficacy of tadalafil once daily in men with diabetes mellitus and erectile dysfunction. Diabet Med 2008; 25: 138-146.
12. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830.
13. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999; 54: 346-351.
14. Rosen RC, Cappelleri JC, Gendrano III N. The International Index of Erectile Function (IIEF): a state-of-the-science review. Int J Impot Res 2002; 14: 226-244.